Funding Rounds
NRG Therapeutics Series A (2022, $18M)
NRG TherapeuticsDrug discovery platform focused on restoring mitochondrial function through therapeutic approaches.
Summary
Stage: Series A
Raised Amount: $18.05M
Raised Date: 2022-01-01
Stage: Series A
Raised Amount: $18.05M
Raised Date: 2022-01-01